These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2875954)

  • 1. Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
    Dal Negro RW; Zoccatelli O; Pomari C; Trevisan F; Turco P
    Int J Clin Pharmacol Res; 1986; 6(4):283-9. PubMed ID: 2875954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
    De Cesaris R; Grimaldi A; Balestrazzi M; Ranieri G; Chiarappa R; Avantaggiato F
    Drugs Exp Clin Res; 1985; 11(10):725-9. PubMed ID: 3836858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of labetalol for the treatment of hypertension in patients with reversible airway obstruction.
    George RB; Light RW; Hudson L; Conrad SA; Manocha KL; Burford JG
    J Clin Hypertens; 1985 Mar; 1(1):80-3. PubMed ID: 3836298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease].
    Chahuán M; Corradi L; Román O; Bravo C
    Rev Med Chil; 2000 Jan; 128(1):59-63. PubMed ID: 10883523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of verapamil in the treatment of hypertension.
    Anavekar SN; Doyle AE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):90S-99S. PubMed ID: 3540229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic consequences of glaucoma treatment with different beta blockers in patients with obstructive respiratory tract diseases].
    Bleckmann H; Dorow P
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):568-72. PubMed ID: 2876127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
    Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
    Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of atenolol on airway resistance in hypertensive patients with chronic obstructive lung disease].
    Molho M; Lidgy M; Ezra D; Rosenthal T
    Harefuah; 1981 Mar; 100(5):220-2. PubMed ID: 7286815
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe respiratory insufficiency induced by selective beta-blocking agents in undiagnosed obstructive lung diseases].
    Simonsson BG; Svensson G
    Lakartidningen; 1981 Sep; 78(37):3161-2. PubMed ID: 6118471
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
    Stone JG; Foëx P; Sear JW; Johnson LL; Khambatta HJ; Triner L
    Anesthesiology; 1988 Apr; 68(4):495-500. PubMed ID: 2895596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioselective beta-blocking agents and respiratory function].
    Dolce E; Misceo N; Partipilo N; Pirrelli A
    Boll Soc Ital Cardiol; 1980; 25(2):187-91. PubMed ID: 6112996
    [No Abstract]   [Full Text] [Related]  

  • 19. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.